Gwajin insulin C-peptide

C-peptide wani abu ne wanda aka kirkira lokacin da aka samar da insulin na hormone kuma aka sake shi cikin jiki. Gwajin insulin C-peptide yana auna adadin wannan samfurin a cikin jini.

Ana bukatar samfurin jini.

Shiri don gwajin ya dogara da dalilin ƙimar C-peptide. Tambayi mai ba ku kiwon lafiya idan ba za ku ci (azumi) ba kafin gwajin. Mai ba ku sabis na iya tambayar ku ku daina shan magungunan da za su iya shafar sakamakon gwajin.

Lokacin da aka saka allurar don zana jini, wasu mutane suna jin matsakaicin ciwo. Wasu kuma suna jin ƙyalli ko harba. Bayan haka, ƙila za a sami wasu harbi ko ɗan rauni. Wannan da sannu zai tafi.

C-peptide ana auna shi don nuna bambanci tsakanin insulin da jiki ke samarwa da kuma insulin da aka shigar cikin jiki.

Wani da ke da ciwon sukari na 1 ko na biyu na iya auna matakin C-peptide don ganin idan jikinsu har yanzu yana samar da insulin. Hakanan ana auna C-peptide idan aka sami karancin sukari a cikin jini don ganin idan jikin mutum yana samar da insulin da yawa.

Hakanan ana yin gwajin sau da yawa don bincika wasu magunguna waɗanda za su iya taimakawa jiki don samar da ƙarin insulin, irin su analogs na pecide na 1 irin na glucagon (GLP-1) ko masu hanawa na DPP IV.

Sakamakon yau da kullun shine tsakanin 0.5 zuwa 2.0 nanogram a kowace milliliter (ng / mL), ko 0.2 zuwa 0.8 nanomoles a kowace lita (nmol / L).

Jeri na darajar yau da kullun na iya ɗan bambanta kaɗan tsakanin ɗakunan gwaje-gwaje daban-daban. Wasu leburori suna amfani da ma'auni daban daban ko gwada samfuran daban. Yi magana da mai baka game da ma'anar takamaiman sakamakon gwajin ka.

Matsakaicin C-peptide ya dogara da matakin sukarin jini. C-peptide alama ce ta cewa jikinku yana samar da insulin. Lowananan matakin (ko babu C-peptide) yana nuna cewa pancreas ɗinku yana samar da ƙarancin insulin.

• Lowananan matakin na iya zama al'ada idan baku ci abinci kwanan nan ba. Yawan sikarin jininku da na insulin a zahiri zai yi ƙasa a lokacin.
• Lowananan matakin ba al'ada ba ne idan jinin jininku ya yi girma kuma ya kamata jikinku yana yin insulin a wannan lokacin.

Mutanen da ke da ciwon sukari na 2, kiba, ko juriya na insulin na iya samun matakin C-peptide mai girma. Wannan yana nufin jikinsu yana samar da insulin mai yawa don kiyaye (ko ƙoƙarin kiyayewa) sukarin jininsu na al'ada.

Akwai ƙananan haɗari tare da ɗaukar jininka. Jijiyoyi da jijiyoyin jini sun bambanta da girma daga mutum ɗaya zuwa wani kuma daga wannan gefen na jikin zuwa wancan. Samun samfurin jini daga wasu mutane na iya zama mai wahala fiye da na wasu.

Sauran haɗarin da ke tattare da ɗaukar jinni ba su da yawa amma suna iya haɗawa da:

• Zuban jini
• Sumewa ko jin an sassauta kai
• Mahara punctures don kokarin gano wuri jijiyoyinmu
• Hematoma (haɓakar jini a ƙarƙashin fata)
• Kamuwa (ƙananan haɗari kowane lokaci fata ta karye)

C-peptide

• Gwajin jini

Atkinson MA, Mcgill DE, Dassau E, Laffel L. Rubuta ciwon sukari na 1 mellitus. A cikin: Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ, eds. Littafin Williams na Endocrinology. 14th ed. Philadelphia, PA: Elsevier; 2020: babi na 36.

Chernecky CC, Berger BJ. C-peptide (haɗa peptide) - magani. A cikin: Chernecky CC, Berger BJ, eds. Gwajin Laboratory da hanyoyin bincike. Na 6 ed. Philadelphia, PA: Elsevier; 2013: 391-392.

Kahn CR, Ferris HA, O'Neill BT. Pathophysiology na nau'in 2 na ciwon sukari mellitus. A cikin: Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ, eds. Littafin Williams na Endocrinology. 14th ed. Philadelphia, PA: Elsevier; 2020: babi na 34.

Pearson ER, McCrimmon RJ. Ciwon suga. A cikin: Ralston SH, ID na Penman, Strachen MWJ, Hobson RP, eds. Ka'idodin Davidson da Aikin Magani. 23 ga ed. Philadelphia, PA: Elsevier; 2020: babi na 20.